A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | ZA | A novel binding site in voltage gated potassium channels revealed by the marine toxin gambierol | Kopljar I., Labro A.J., Cuypers E., Rainier J., Tytgat J., Snyders D. | | Acceleration of hERG1 channel activation and deactivation by the amiodarone derivative KB130015 | Macianskiene R., Gwanyanya A., Gessner G., Heinemann S.H., Mubagwa K., Starkus J.G. | | Altered striatal glutamate transporter functioning could explain aberrant glutamatergic neurotransmission in striatum of hemi-parkinson rat model | Massie A., Goursaud S., Schallier A., Vermoesen K., Arckens L., Meshul C., Hermans E., Michotte Y. | | Analysis of renal phenotype of hyaluronidase-1 or hyaluronidase-2 knockout mice | Colombaro V., Voisin V., Decleves A.E., Giordano L., Habsch I., Flamion B., Caron N. | | Anticonvulsant effects of ghrelin receptor ligands against pilocarpine-induced limbic seizures | Portelli J., Aourz N., Ver Donck L., Michotte Y., Smolders I. | | Anticonvulsive effects of insulin-regulated aminopeptidase deletion in a pentylenetetrazol mouse seizure model are not mediated by the accumulation of somatostatin-14 | Loyens E., Schallier A., De Bundel D., Demaegdt H., Chai S.Y., Albiston A.L., Vauquelin G., Vanderheyden P., Michotte Y., Smolders I. | | Apomorphine induced neuroprotection in an animal model of parkinsons disease | Varcin M., Yuan H., Mertens B., Michotte Y., Sarre S. | |
|